- Home
- BNGO vs CING Comparison
BNGO vs CING Comparison
Compare BNGO & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNGO
- CING
- Stock Information
- Founded
- BNGO 2003
- CING 2012
- Country
- BNGO United States
- CING United States
- Employees
- BNGO N/A
- CING N/A
- Industry
- BNGO Biotechnology: Laboratory Analytical Instruments
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- BNGO Industrials
- CING Health Care
- Exchange
- BNGO Nasdaq
- CING Nasdaq
- Market Cap
- BNGO 24.3M
- CING 21.6M
- IPO Year
- BNGO 2018
- CING 2021
- Fundamental
- Price
- BNGO $1.60
- CING $3.77
- Analyst Decision
- BNGO Buy
- CING Strong Buy
- Analyst Count
- BNGO 4
- CING 4
- Target Price
- BNGO $7.67
- CING $33.00
- AVG Volume (30 Days)
- BNGO 307.7K
- CING 196.5K
- Earning Date
- BNGO 11-13-2025
- CING 11-07-2025
- Dividend Yield
- BNGO N/A
- CING N/A
- EPS Growth
- BNGO N/A
- CING N/A
- EPS
- BNGO N/A
- CING N/A
- Revenue
- BNGO $27,426,000.00
- CING N/A
- Revenue This Year
- BNGO N/A
- CING N/A
- Revenue Next Year
- BNGO $24.54
- CING N/A
- P/E Ratio
- BNGO N/A
- CING N/A
- Revenue Growth
- BNGO N/A
- CING N/A
- 52 Week Low
- BNGO $1.50
- CING $3.28
- 52 Week High
- BNGO $22.80
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- BNGO 31.42
- CING 50.33
- Support Level
- BNGO $1.52
- CING $3.57
- Resistance Level
- BNGO $1.70
- CING $3.80
- Average True Range (ATR)
- BNGO 0.08
- CING 0.20
- MACD
- BNGO 0.00
- CING 0.01
- Stochastic Oscillator
- BNGO 15.56
- CING 53.85
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.